Identifai Genetics Analytic Validity Study - Compound Heterozygosity and Samples Collection

NCT06239077 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-02-02

No results posted yet for this study

Summary

The purpose of this study is to validate a noninvasive prenatal diagnosis procedure for genetic conditions in the developing fetus by analyzing fetal genetic material present in the pregnant mother's blood.

Conditions

  • Prenatal Diagnosis
  • Genetics

Interventions

OTHER

Non Invasive Prenatal Test via blood sample

Maternal - blood draw, Paternal - blood draw/Saliva sample

Sponsors & Collaborators

  • Identifai Genetics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-05
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06239077 on ClinicalTrials.gov